MedTrace Logo

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

NCT04618575 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2021-03-24

No results posted yet for this study

Summary

A randomized controlled open-label clinical trial of ursodeoxycholic acid combined with total glucosides of paeony in the treatment of PBC with AIH features 1

Conditions

Interventions

DRUG

Ursodeoxycholic acid combined with total glucosides of paeony

Ursodeoxycholic acid combined with total glucosides of paeony

DRUG

Ursodeoxycholic acid only

Ursodeoxycholic acid only

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Li Yang, MD · West China Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-17
Primary Completion
2022-11-05
Completion
2022-11-05

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04618575 on ClinicalTrials.gov